Miriam Wilmes
Overview
Explore the profile of Miriam Wilmes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
355
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shprung T, Wani N, Wilmes M, Mangoni M, Bitler A, Shimoni E, et al.
Biochemistry
. 2021 Sep;
60(39):2943-2955.
PMID: 34547893
The increasing number of resistant bacteria is a major threat worldwide, leading to the search for new antibiotic agents. One of the leading strategies is the use of antimicrobial peptides...
2.
Wilmes M, Meier K, Schiefer A, Josten M, Otten C, Klockner A, et al.
Front Cell Infect Microbiol
. 2017 Aug;
7:353.
PMID: 28824885
endobacteria are obligate intracellular bacteria with a highly reduced genome infecting many arthropod and filarial species, in which they manipulate arthropod reproduction to increase their transmission and are essential for...
3.
Raafat D, Leib N, Wilmes M, Francois P, Schrenzel J, Sahl H
Carbohydr Polym
. 2016 Dec;
157:146-155.
PMID: 27987856
The bacterial cell envelope is believed to be a principal target for initiating the staphylocidal pathway of chitosan. The present study was therefore designed to investigate possible changes in cell...
4.
Wilmes M, Sahl H
Methods Mol Biol
. 2016 Nov;
1520:133-143.
PMID: 27873250
The bacterial cytoplasmic membrane separates the cell from its environment and acts as a selective permeability barrier. In addition, it functions in energy conservation, transport, and biosynthesis processes. Antimicrobial agents...
5.
Wilmes M, Stockem M, Bierbaum G, Schlag M, Gotz F, Tran D, et al.
Antibiotics (Basel)
. 2015 Jan;
3(4):617-31.
PMID: 25632351
θ-Defensins are cyclic antimicrobial peptides expressed in leukocytes of Old world monkeys. To get insight into their antibacterial mode of action, we studied the activity of RTDs (rhesus macaque θ-defensins)...
6.
Wilmes M, Sahl H
Int J Med Microbiol
. 2013 Oct;
304(1):93-9.
PMID: 24119539
Cationic and amphiphilic peptides are widely distributed in eukaryotic organisms and constitute a first line of host defense against invading pathogens. Some of these host defense peptides (HDPs) combine specific...
7.
Ulm H, Wilmes M, Shai Y, Sahl H
Front Immunol
. 2012 Aug;
3:249.
PMID: 22912635
No abstract available.
8.
Wilmes M, Cammue B, Sahl H, Thevissen K
Nat Prod Rep
. 2011 May;
28(8):1350-8.
PMID: 21617811
Defensins are small basic amphiphilic peptides (up to 5 kDa) that have been shown to be important effector molecules of the innate immune system of animals, plants and fungi. In...
9.
Schmitt P, Wilmes M, Pugniere M, Aumelas A, Bachere E, Sahl H, et al.
J Biol Chem
. 2010 Jul;
285(38):29208-16.
PMID: 20605792
Three oyster defensin variants (Cg-Defh1, Cg-Defh2, and Cg-Defm) were produced as recombinant peptides and characterized in terms of activities and mechanism of action. In agreement with their spectrum of activity...
10.
Sass V, Schneider T, Wilmes M, Korner C, Tossi A, Novikova N, et al.
Infect Immun
. 2010 Apr;
78(6):2793-800.
PMID: 20385753
Human beta-defensin 3 (hBD3) is a highly charged (+11) cationic host defense peptide, produced by epithelial cells and neutrophils. hBD3 retains antimicrobial activity against a broad range of pathogens, including...